Rainier Group Investment Advisory LLC Has $395,000 Holdings in Merck & Company, Inc. (NYSE:MRK)

Rainier Group Investment Advisory LLC continued to hold its position in shares of Merck & Company, Inc. (NYSE:MRK) during the first quarter, according to its most recent disclosure with the SEC. The firm owned 6,222 shares of the company’s stock at the close of the first quarter. Merck & accounts for about 0.2% of Rainier Group Investment Advisory LLC’s holdings, making the stock its 28th largest holding. Rainier Group Investment Advisory LLC’s holdings in Merck & were worth $395,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. HM Capital Management LLC grew its position in Merck & by 0.4% in the 1st quarter. HM Capital Management LLC now owns 3,734 shares of the company’s stock worth $236,000 after purchasing an additional 15 shares during the last quarter. City Holding Co. boosted its holdings in shares of Merck & by 0.4% in the first quarter. City Holding Co. now owns 7,767 shares of the company’s stock valued at $494,000 after acquiring an additional 31 shares in the last quarter. Camelot Portfolios LLC boosted its holdings in shares of Merck & by 0.4% in the first quarter. Camelot Portfolios LLC now owns 7,771 shares of the company’s stock valued at $494,000 after acquiring an additional 33 shares in the last quarter. Adirondack Trust Co. boosted its holdings in shares of Merck & by 0.4% in the first quarter. Adirondack Trust Co. now owns 11,334 shares of the company’s stock valued at $720,000 after acquiring an additional 41 shares in the last quarter. Finally, Northstar Group Inc. boosted its holdings in shares of Merck & by 0.5% in the first quarter. Northstar Group Inc. now owns 12,778 shares of the company’s stock valued at $811,000 after acquiring an additional 58 shares in the last quarter. Hedge funds and other institutional investors own 73.02% of the company’s stock.

Shares of Merck & Company, Inc. (NYSE MRK) traded up 0.06% during midday trading on Friday, hitting $66.16. 14,685,767 shares of the company traded hands. The stock’s 50-day moving average is $63.41 and its 200 day moving average is $63.72. Merck & Company, Inc. has a 12-month low of $58.29 and a 12-month high of $66.80. The stock has a market capitalization of $180.44 billion, a P/E ratio of 35.82 and a beta of 0.81.

Merck & (NYSE:MRK) last announced its quarterly earnings data on Friday, July 28th. The company reported $1.01 EPS for the quarter, topping the Zacks’ consensus estimate of $0.87 by $0.14. The business had revenue of $9.93 billion for the quarter, compared to analyst estimates of $9.75 billion. Merck & had a net margin of 17.14% and a return on equity of 26.02%. The firm’s revenue for the quarter was up .9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.93 earnings per share. On average, analysts expect that Merck & Company, Inc. will post $3.87 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 6th. Stockholders of record on Friday, September 15th will be given a $0.47 dividend. This represents a $1.88 dividend on an annualized basis and a dividend yield of 2.84%. The ex-dividend date is Thursday, September 14th. Merck &’s dividend payout ratio is presently 76.11%.

TRADEMARK VIOLATION WARNING: “Rainier Group Investment Advisory LLC Has $395,000 Holdings in Merck & Company, Inc. (NYSE:MRK)” was originally reported by BBNS and is owned by of BBNS. If you are reading this piece on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://baseballnewssource.com/markets/merck-company-inc-mrk-stake-maintained-by-rainier-group-investment-advisory-llc/1566546.html.

Several research firms have recently issued reports on MRK. BidaskClub cut shares of Merck & from a “sell” rating to a “strong sell” rating in a report on Wednesday, July 19th. BMO Capital Markets reiterated an “outperform” rating and issued a $73.00 price objective (down from $74.00) on shares of Merck & in a report on Monday, July 24th. Citigroup Inc. set a $65.00 price objective on shares of Merck & and gave the company a “hold” rating in a report on Wednesday, July 5th. Zacks Investment Research cut shares of Merck & from a “buy” rating to a “hold” rating in a report on Thursday, May 25th. Finally, Jefferies Group LLC reiterated a “sell” rating and issued a $51.00 price objective on shares of Merck & in a report on Wednesday, May 24th. Two research analysts have rated the stock with a sell rating, eight have given a hold rating and twelve have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $70.00.

Merck & Company Profile

Merck & Co, Inc is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company’s Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures.

Institutional Ownership by Quarter for Merck & (NYSE:MRK)

Receive News & Ratings for Merck & Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck & Company Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Young Girl Hit by Foul Ball Rushed to Hospital
Young Girl Hit by Foul Ball Rushed to Hospital
New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?
Cleveland Indians Winning Streak Snapped at 22
Cleveland Indians Winning Streak Snapped at 22
Tigers Player Might Play All Nine Positions During Same Game
Tigers Player Might Play All Nine Positions During Same Game
Fans Kicked Out of Fenway Park After Racist Banner Hung on Green Monster
Fans Kicked Out of Fenway Park After Racist Banner Hung on Green Monster


Leave a Reply

 
© 2006-2017 BBNS.